Earnings Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts 1 month ago Beyond Air, Inc. (NASDAQ: XAIR) released strong Q3 FY2026 earnings. As a result, shares rose during intraday trading. Investors reacted… Credicorp Shares Fall 2% After Q4 Earnings Miss Despite Record Full-Year Profit 1 month ago Credicorp Ltd (NYSE: BAP) shares slid in early trading on results that missed Street expectations for the fourth quarter. BAP… Enbridge Gains 4% as Q4 Earnings Top Estimates, Full-Year Cash Flow Climbs 1 month ago Enbridge Inc. (NYSE: ENB) shares climbed in early trading after the Canadian pipeline operator reported fourth-quarter and full-year 2025 results… Wendy’s shares tumble on weak 2026 outlook, U.S. sales slump 1 month ago Shares of The Wendy’s Company (Nasdaq: WEN) fell 6.5% to $6.80 in Friday afternoon trading as the fast-food chain’s disappointing… Cameco Shares Fall After Reporting Higher Q4 Profit and Strong Full-Year Growth 1 month ago Shares of Cameco Corp. (NYSE: CCJ) were trading lower on Friday, slipping about 2.9% to $112.97 in midday New York… GEE Group Inc. Narrows Q1 2026 Loss as Margin Expansion Offsets Revenue Contraction 1 month ago GEE Group Inc. (NYSE American: JOB), a diversified provider of professional staffing and human resource solutions, announced its financial results… Cooper Standard Reports Strong Q4 Revenue and Record EV Awards 1 month ago Cooper-Standard Holdings Inc. (NYSE: CPS) reported its fourth-quarter and full-year 2025 financial results on February 12, 2026, revealing a complex… Rithm Property Trust Marks 2025 Turnaround; Shifts Focus to Commercial Credit 1 month ago Rithm Property Trust Inc. (NYSE: RPT), the externally managed real estate investment vehicle of Rithm Capital Corp., released its fourth-quarter… Roku stock rises after Q4 FY25 earnings beat estimates; revenue up 16% 1 month ago Roku, Inc. (NASDAQ: ROKU) has reported a double-digit growth in revenues for the fourth quarter of fiscal 2025. The media… Vertex Pharma Q4 2025 Earnings Results 1 month ago Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis… Next» « Previous